Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186M
-
Number of holders
-
278
-
Total 13F shares, excl. options
-
193M
-
Shares change
-
+17.3M
-
Total reported value, excl. options
-
$8.45B
-
Value change
-
+$749M
-
Put/Call ratio
-
1.15
-
Number of buys
-
168
-
Number of sells
-
-86
-
Price
-
$43.74
Significant Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q4 2024
326 filings reported holding RVMD - Revolution Medicines, Inc. - Common Stock as of Q4 2024.
Revolution Medicines, Inc. - Common Stock (RVMD) has 278 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 193M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (17.1M shares), BlackRock, Inc. (14.7M shares), FARALLON CAPITAL MANAGEMENT LLC (13.2M shares), WELLINGTON MANAGEMENT GROUP LLP (10.8M shares), JANUS HENDERSON GROUP PLC (9.48M shares), BAKER BROS. ADVISORS LP (7.94M shares), Nextech Invest Ltd. (7.6M shares), FMR LLC (6.74M shares), Paradigm Biocapital Advisors LP (6.55M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (5.87M shares).
This table shows the top 278 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.